Evidence map›Paper›PMID 42352885›Full record

ArticleInternational journal of molecular sciences2026

New Insights into Iodide Transport Defects (ITDs) from the Characterization of a Heterozygous NIS Missense Variant (p.G288S) Identified in a Family with Thyroid Dysfunction During Pregnancy.

Maddi Garate-Etxeberria, Mari Paz Lopez-Molina, Rafael Hortiguela, Pouya Alikhani, María De la Calle, Custodia García-Jimenez, Jose Carlos Moreno, Antonio De la Vieja

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maddi Garate-EtxeberriaTumor Endocrine Unit, Chronic Disease Program (UFIEC), Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km 2.2, 28220 Madrid, Spain.ORCID 0009-0006-8629-2818
Mari Paz Lopez-MolinaTumor Endocrine Unit, Chronic Disease Program (UFIEC), Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km 2.2, 28220 Madrid, Spain.ORCID 0000-0002-9171-2606
Rafael HortiguelaTumor Endocrine Unit, Chronic Disease Program (UFIEC), Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km 2.2, 28220 Madrid, Spain.
Pouya AlikhaniThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital Research Institute (IdiPAZ), 28029 Madrid, Spain.
María De la CalleDepartment of Obstetrics and Gynecology, La Paz University Hospital, 28046 Madrid, Spain.
Custodia García-JimenezArea of Physiology, Faculty of Health Sciences, University Rey Juan Carlos (URJC), 28922 Madrid, Spain.
Jose Carlos MorenoThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital Research Institute (IdiPAZ), 28029 Madrid, Spain.
Antonio De la ViejaTumor Endocrine Unit, Chronic Disease Program (UFIEC), Instituto de Salud Carlos III, Ctra. Majadahonda a Pozuelo km 2.2, 28220 Madrid, Spain.ORCID 0000-0002-1187-1907

Funding

Instituto de Salud Carlos III PI24CIII/00054Ministerio de Ciencia, Innovación y Universidades PID2021-125948OB-I00/AEI/10.13039/501100011033
6 · The paper itself

Abstract

The Na

Indexed as

IodidesMutation, MissensePregnancy ComplicationsSymportersThyroid DiseasesBiological TransportFemaleHEK293 CellsHeterozygoteHumansPedigreePregnancySodium-Iodide SymportersIodidesSodium-Iodide SymportersSymportersheterozygous variantiodide affinityiodide transport defectNIS dimerizationNIS traffickingSLC5A5sodium/iodide symporterthyroid dysfunction during pregnancy

Identifiers

PMID42352885
PMCPMC13299470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.